GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure - PubMed (original) (raw)

doi: 10.1038/nm.3128. Epub 2013 Mar 31.

Affiliations

Minsuk Kim et al. Nat Med. 2013 May.

Abstract

Glucagon-like peptide-1 receptor (GLP-1R) agonists exert antihypertensive actions through incompletely understood mechanisms. Here we demonstrate that cardiac Glp1r expression is localized to cardiac atria and that GLP-1R activation promotes the secretion of atrial natriuretic peptide (ANP) and a reduction of blood pressure. Consistent with an indirect ANP-dependent mechanism for the antihypertensive effects of GLP-1R activation, the GLP-1R agonist liraglutide did not directly increase the amount of cyclic GMP (cGMP) or relax preconstricted aortic rings; however, conditioned medium from liraglutide-treated hearts relaxed aortic rings in an endothelium-independent, GLP-1R-dependent manner. Liraglutide did not induce ANP secretion, vasorelaxation or lower blood pressure in Glp1r(-/-) or Nppa(-/-) mice. Cardiomyocyte GLP-1R activation promoted the translocation of the Rap guanine nucleotide exchange factor Epac2 (also known as Rapgef4) to the membrane, whereas Epac2 deficiency eliminated GLP-1R-dependent stimulation of ANP secretion. Plasma ANP concentrations were increased after refeeding in wild-type but not Glp1r(-/-) mice, and liraglutide increased urine sodium excretion in wild-type but not Nppa(-/-) mice. These findings define a gut-heart GLP-1R-dependent and ANP-dependent axis that regulates blood pressure.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Am J Physiol Renal Physiol. 2009 Dec;297(6):F1647-55 - PubMed
    1. FASEB J. 2004 May;18(7):908-10 - PubMed
    1. Am J Cardiol. 2011 Aug 2;108(3 Suppl):52B-8B - PubMed
    1. Nat Rev Drug Discov. 2010 Apr;9(4):267-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7661-4 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources